Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¸¸¼º ¾ËÄڿüº °£¿°¿¡ ´ëÇÑ ÀÓ»ó ¹× º´¸®ÇÐÀû °Ë»ö A Clinicopathologic Study on Chronic Alcoholic Hepatitis

´ëÇѺ´¸®ÇÐȸÁö 1988³â 22±Ç 4È£ p.393 ~ 403
Çã±â¿µ, Á¤±Ô¼·,
¼Ò¼Ó »ó¼¼Á¤º¸
Çã±â¿µ (  ) 
ºÎ»ê´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç

Á¤±Ô¼· (  ) 
ºÎ»ê´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç

Abstract

¿ä ¾à
ÀúÀÚ´Â ¸¸¼º ¾ËÄڿüº °£¿°¿¡¼­ °üÂûµÈ ÀÓ»ó ¹× º´¸®Á¶Á÷ÇÐÀû ¼Ò°ßµé Áß ÀÌ ÁúȯÀÇ Áø´Ü
¿¡ À¯ÀǼº ÀÖ´Â °ÍµéÀ» Á¶»çÇϱâ À§ÇÏ¿© º» ¿¬±¸¸¦ ½ÃµµÇÏ¿´´Ù. ÀúÀÚ´Â °ú°Å 9³â°£ ºÎ»ê´ë
Çб³ ÀÇ°ú´ëÇÐ ºÎ¼Óº´¿ø Çغκ´¸®°ú¿¡¼­ Áø´ÜµÈ CALH 20¿¹ ¹× CAVH 28¿¹¸¦ ´ë»óÀ¸·Î ¼º
º° ¹× ¿¬·Éº° ºóµµ, Áß¿ä ÀÓ»óÁõ»ó, °Ë»ç½Ç ¼Ò°ß ¹× º´¸®Á¶Á÷ÇÐÀû ¼Ò°ßµéÀ» ºñ±³ºÐ¼® ÇÏ¿´
´Ù. ÀÌ·¸°Ô ÇÏ¿© ¾òÀº ¼ºÀûÀ» ´ÙÀ½°ú °°ÀÌ ¿ä¾àÇÑ´Ù.
CALH´Â ³²ÀÚ°¡ 15¿¹, ¿©ÀÚ°¡ 5¿¹·Î¼­ ³²¿©ºñ´Â 3 :1À̾ú°í, ¿¬·ÉºÐÆ÷´Â 20´ë·ÎºÎÅÍ 60´ë
±îÁö ±¤¹üÇÏ¿´À¸¸ç, CAVHÀÇ ¼ºº° ¹× ¿¬·Éº° ºóµµ¿¡ ºñ±³ÇÏ¿© ƯÀÌÇÑ Á¡ÀÌ ÀÎÁ¤µÇÁö ¾Æ´Ï
ÇÏ¿´´Ù. CALHÀÇ Áß¿ä ÀÓ»óÁõ»óÀº °£ºñ´ë (85%), Ȳ´Þ(75%) ¹× º¹ºÎµÐÅë(50%) À̾ú´Âµ¥,
CAVHÀÇ ÀÓ»óÁõ»ó°ú ºñ±³ÇÏ¿© ƯÀÌÇÑ Á¡ÀÌ ¹ß°ßµÇÁö ¾Æ´ÏÇÏ¿´´Ù.
ù Áø´Ü½Ã CALHÀÇ ºñÁ¤»óÄ¡¸¦ ³ªÅ¸³½ Áß¿ä °Ë»ç½Ç ¼Ò°ßÀº Ç÷û r-GTP È°¼ºÄ¡ (100%),
SGOT(95%), SGPT(75%), Ç÷û alkaline phosphatase È°¼ºÄ¡ (60%) ¹× Ç÷û ÃÑ bilirubin³ó
µµ(60%)¿´´Ù. CAVHÀÇ °Ë»ç½Ç ¼Ò°ß°ú ºñ±³ÇÏ¿© ÀÌ ÁúȯÀÇ Áø´Ü¿¡ µµ¿òÀÌ µÈ´Ù°í
ÀÎÁ¤µÈ Ç׸ñÀº Ç÷û r-GTP ¹× alkaline phosphatase È°¼ºÄ¡¿´´Ù. CALH ¿¹µéÀÇ °£½ÇÁú¿¡¼­
°üÂûµÈ º´¸®Á¶Á÷ÇÐÀû ¼Ò°ßµé Áõ CAVHÀÇ ¼Ò°ßµé°ú ºñ±³ÇÏ¿© À¯ÀÇÀû À̶ó°í ÆÇÁ¤µÈ °ÍµéÀº
°£¼¼Æ÷ÀÇ Áö¹æº¯¼º (100%), °ú¸³»ó ÀÀ°í¸¦ µ¿¹ÝÇÑ ¼öÁ¾¼º º¯¼º(100%), ¼¶¼¼ÇÑ ¼¶À¯Á¶Á÷ Áõ
½Ä(85%), ´ãÁóÀÇ ¿ïÀû (35%), ±×¸®°í Mallory¼ÒüÀÇ ÃâÇö(20%) À̾úÀ¸¸ç, ¹®¸Æ¾ß ¹× ¹®¸Æ¾ß
ÁÖÀ§ °£ÁúÁ¶Á÷¿¡¼­ °üÂûµÈ À¯ÀÇÀûÀÎ º´¸®Á¶Á÷ÇÐÀû ¼Ò°ßÀº ÇÑ°èÆÇÀÇ ºÒ¸íÈ­(60%)À̾ú´Ù.
#ÃÊ·Ï#
This study was undertaken to evaluate the significant diagnostic points of chronic
alcoholic hepatitis (CALH) among clinicopathologic findings observed. The specimens
used in this study were 20 cases of CALH and 28 cases of chronic active viral hepatitis
(CAVH), which were diagnosed at our University Hospital during 9years period from
1978 to 1987 In these cases, comparative analysis of age and sex distribution, major
clinical manifestations, and laboratory and histopathologic findings was performed.
The results chained were summarized as follows:
Among 20 cases of CALH, the sex distribution was 15 in male and 5 in female with
a ratio of 3:1. The range of age distribution was wide from third to seventh decade.
There was no recognizable special point about the age and sex distribution of CALH,
compared with cases of CAVH. Major clinical manifestations of CALH were
hepatomegaly (85%), jaundice (75%) and abdominal pain (50%). Also there was no
recognizable special point about the major clinical manifestations of CALH, compared
with cases of CAVH. Abnormal values of major laboratory items in CALH were
observed in activities of serum r-GTP (100%), 5G07 (95%), SGPT (75%) and serum
alkaline phosphatase (60%), and total serum bilirubin (60%).
Compared with CAVH in major laboratory findings, the significant diagnostic items of
CALH were the activities of serum r-GTP and alkaline phosphatase.
The characteristic histopathologic findings of CALH, which were compared with
CAVH and observed in liver parenchyma, were fatty change (100%), cytoplasmic
ballooning and coagulation (100%), delicate fibrosis (85%), bile stagnation (35%), and
Mallory bodies (20%), and that observed blurring of limiting plate (60%) in portal and
periportal areas.

Å°¿öµå

Chronic alcoholic hepatitis; chronic active viral hepatitis;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS